Peter Seiringer

418 total citations
16 papers, 234 citations indexed

About

Peter Seiringer is a scholar working on Dermatology, Epidemiology and Immunology. According to data from OpenAlex, Peter Seiringer has authored 16 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Dermatology, 6 papers in Epidemiology and 5 papers in Immunology. Recurrent topics in Peter Seiringer's work include Dermatology and Skin Diseases (6 papers), Autoimmune Bullous Skin Diseases (4 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Peter Seiringer is often cited by papers focused on Dermatology and Skin Diseases (6 papers), Autoimmune Bullous Skin Diseases (4 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Peter Seiringer collaborates with scholars based in Germany, Sweden and Spain. Peter Seiringer's co-authors include Kilian Eyerich, Natalie Garzorz‐Stark, Tilo Biedermann, Emanuele Scala, Sara Cacciapuoti, Claudio Marasca, Thomas Volz, Gabriella Fabbrocini, Matteo Megna and Felix Lauffer and has published in prestigious journals such as Frontiers in Immunology, Journal of Investigative Dermatology and Journal of Affective Disorders.

In The Last Decade

Peter Seiringer

13 papers receiving 232 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Seiringer Germany 9 121 99 54 44 40 16 234
İsa An Türkiye 9 61 0.5× 26 0.3× 57 1.1× 66 1.5× 41 1.0× 64 254
Aurora Guerra Tàpia Spain 7 83 0.7× 80 0.8× 21 0.4× 18 0.4× 17 0.4× 51 217
Ashok Kumar Khare India 8 108 0.9× 86 0.9× 20 0.4× 87 2.0× 21 0.5× 24 248
Ali Sadeghinia Iran 10 148 1.2× 115 1.2× 40 0.7× 211 4.8× 36 0.9× 21 419
Giulia Merlo Italy 9 148 1.2× 92 0.9× 11 0.2× 20 0.5× 26 0.7× 15 286
A. Nuño‐González Spain 8 126 1.0× 86 0.9× 34 0.6× 39 0.9× 28 0.7× 22 220
Doaa Salah Hegab Egypt 12 152 1.3× 72 0.7× 39 0.7× 7 0.2× 52 1.3× 25 300
Nicola Aste Italy 13 130 1.1× 328 3.3× 13 0.2× 27 0.6× 42 1.1× 19 441
William T. McGaw Canada 8 59 0.5× 153 1.5× 76 1.4× 6 0.1× 25 0.6× 11 279
VikramK Mahajan India 10 47 0.4× 119 1.2× 18 0.3× 44 1.0× 24 0.6× 19 256

Countries citing papers authored by Peter Seiringer

Since Specialization
Citations

This map shows the geographic impact of Peter Seiringer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Seiringer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Seiringer more than expected).

Fields of papers citing papers by Peter Seiringer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Seiringer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Seiringer. The network helps show where Peter Seiringer may publish in the future.

Co-authorship network of co-authors of Peter Seiringer

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Seiringer. A scholar is included among the top collaborators of Peter Seiringer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Seiringer. Peter Seiringer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Seiringer, Peter, Manja Jargosch, Carsten B. Schmidt‐Weber, et al.. (2025). Tyrosine kinase 2 inhibition improves clinical and molecular hallmarks in subtypes of cutaneous lupus. British Journal of Dermatology. 193(6). 1192–1203.
2.
Böhner, Alexander, et al.. (2025). A phase IIb single‐center study to assess the efficacy of apremilast for the treatment of nummular eczema. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 23(8). 959–965.
3.
Mubarak, Mohammad S., Peter Seiringer, Michael P. Menden, et al.. (2024). Death-Associated Protein Kinase 1 Dampens Keratinocyte Necroptosis and Expression of Inflammatory Genes in Lichen Planus. Journal of Investigative Dermatology. 145(8). 1921–1929.e13.
4.
Seiringer, Peter, Manja Jargosch, Stefanie Eyerich, et al.. (2024). Spatial transcriptomics reveals altered lipid metabolism and inflammation-related gene expression of sebaceous glands in psoriasis and atopic dermatitis. Frontiers in Immunology. 15. 1334844–1334844. 12 indexed citations
5.
Scala, Emanuele, Sara Cacciapuoti, Natalie Garzorz‐Stark, et al.. (2021). Hidradenitis Suppurativa: Where We Are and Where We Are Going. Cells. 10(8). 2094–2094. 74 indexed citations
6.
Jargosch, Manja, Peter Seiringer, Kristina Schwamborn, et al.. (2021). Immunocompromised Patients with Therapy-Refractory Chronic Skin Diseases Show Reactivation of Latent Epstein‒Barr Virus and Cytomegalovirus Infection. Journal of Investigative Dermatology. 142(3). 549–558.e6. 3 indexed citations
7.
Jacob, Louis, et al.. (2021). Association between skin disorders and depression in children and adolescents: A retrospective case-control study. Journal of Affective Disorders. 282. 939–944. 9 indexed citations
8.
Seiringer, Peter, Natalie Garzorz‐Stark, & Kilian Eyerich. (2021). T-Cell‒Mediated Autoimmunity: Mechanisms and Future Directions. Journal of Investigative Dermatology. 142(3). 804–810. 16 indexed citations
9.
Lauffer, Felix, et al.. (2021). 044 Safety and efficacy of anti-IL-17 (Secukinumab) for the treatment of pyoderma gangrenosum. Journal of Investigative Dermatology. 141(10). S156–S156. 6 indexed citations
10.
Tizek, Linda, et al.. (2021). Interest in Sexually Transmitted Infections: Analysis of Web Search Data Terms in Eleven Large German Cities from 2015 to 2019. International Journal of Environmental Research and Public Health. 18(5). 2771–2771. 5 indexed citations
11.
Seiringer, Peter, Stefanie Eyerich, Kilian Eyerich, et al.. (2021). Keratinocytes Regulate the Threshold of Inflammation by Inhibiting T Cell Effector Functions. Cells. 10(7). 1606–1606. 9 indexed citations
12.
Seiringer, Peter, et al.. (2020). Tofacitinib in Hypertrophic Lichen Planus. Acta Dermato Venereologica. 100(14). adv00220–adv00220. 21 indexed citations
13.
Seiringer, Peter, Tilo Biedermann, & Knut Brockow. (2020). Psoriasiform Dermatitis During Infliximab Therapy for Ulcerative Colitis. Deutsches Ärzteblatt international. 117(39). 652–652. 1 indexed citations
14.
Seiringer, Peter, et al.. (2019). Treatment of Pityriasis Rubra Pilaris With Guselkumab. JAMA Dermatology. 155(12). 1424–1424. 18 indexed citations
15.
Seiringer, Peter, Michael Pritsch, María Flóres-Chávez, et al.. (2017). Comparison of four PCR methods for efficient detection of Trypanosoma cruzi in routine diagnostics. Diagnostic Microbiology and Infectious Disease. 88(3). 225–232. 29 indexed citations
16.
Navarro, Miriam, Nicole Berens‐Riha, Peter Seiringer, et al.. (2017). Cross-sectional, descriptive study of Chagas disease among citizens of Bolivian origin living in Munich, Germany. BMJ Open. 7(1). e013960–e013960. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026